| Dr Lucy Miller, MD | |
|
353 Blair Park Rd, Williston, VT 05495-7530 | |
| (802) 847-1470 | |
| Not Available |
| Full Name | Dr Lucy Miller |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 353 Blair Park Rd, Williston, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013072347 | NPI | - | NPPES |
| 0VN1623 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care | Williston, VT | Home health agency |
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Copley Hospital | Morrisville, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).
A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.
Pesticides, pharmaceutical products, and endocrine disruptors are some of the emerging contaminants often found in treated domestic wastewater, even after secondary treatment.
Abbott (NYSE: ABT) announced today that the Chinese State Food and Drug Administration (SFDA) has approved its XIENCE V(R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS(R) Paclitaxel-Eluting Coronary Stent System (TAXUS) in the primary endpoints of two randomized, pivotal (phase III) clinical trials.
› Verified 7 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).
A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.
Pesticides, pharmaceutical products, and endocrine disruptors are some of the emerging contaminants often found in treated domestic wastewater, even after secondary treatment.
Abbott (NYSE: ABT) announced today that the Chinese State Food and Drug Administration (SFDA) has approved its XIENCE V(R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS(R) Paclitaxel-Eluting Coronary Stent System (TAXUS) in the primary endpoints of two randomized, pivotal (phase III) clinical trials.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lucy Miller, MD 46 Lawnwood Dr, Williston, VT 05495-9316 Ph: (802) 878-0238 | Dr Lucy Miller, MD 353 Blair Park Rd, Williston, VT 05495-7530 Ph: (802) 847-1470 |
News Archive
Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).
A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.
Pesticides, pharmaceutical products, and endocrine disruptors are some of the emerging contaminants often found in treated domestic wastewater, even after secondary treatment.
Abbott (NYSE: ABT) announced today that the Chinese State Food and Drug Administration (SFDA) has approved its XIENCE V(R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS(R) Paclitaxel-Eluting Coronary Stent System (TAXUS) in the primary endpoints of two randomized, pivotal (phase III) clinical trials.
› Verified 7 days ago
Dr. Dennis Armand Plante, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 Fax: 802-847-7135 | |
Dr. Marvin Klikunas, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 Fax: 802-847-7135 | |
Owen David Maguire, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 | |
Jonathan Benjamin Wilfong, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 Fax: 802-847-7135 | |
Anne E Brena, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 | |
Alexandra L Messerli, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1470 Fax: 802-847-7135 |